P43  Endogenous inhibitors of cysteine proteases cystatin C and cystatin SN in biological fluids of patients with intraocular melanoma as possible biomarkers and therapy targets by Dikovskaya, M. et al.
hyphenated to an Impact UHR-qTOF mass analyzer (Bruker
Daltonics, Germany). Reversed-phase experiments (RPLC) were
performed with an UHPLC BEH Shield RP18 column
100  2.1 mm, 1.7 lm (Waters) and HILIC experiments with a Luna
HILIC column (Phenomenex, The Netherlands) of 100  2.00 mm,
3 lm. RPLC data were acquired in ESI positive mode and HILIC in
negative mode, respectively. The data acquisition rate was set to
1 Hz over a mass range of m/z 50–1000. The LC–MS data files were
aligned by using the in-house developed alignment algorithm
MS-Align 2 tool (www.ms-utils.org/msalign2).
Results: After the data prepressing, which includes alignment,
noise filtering and peak picking two data matrixes costing of 412
features (metabolites) for RPLC and 428 ones for HILIC were
generated. To evaluate a degree of similarity between the two
data matrixes the RV coefficient (a multivariate extension of
correlation coefficient) was used. The coefficient has flattened
at 0.58 showing that despite a strong overlap between the data-
sets there is a substantial number of the ‘‘platform specific”
metabolites. Those structures will certainly be missed if a single
platform strategy is applied.
Conclusion: Here we present for the first time a cross-platform
mass spectrometric analysis of bile juice collected from the
patients cholangiocarcinoma-associated diseases. We show that
a combination of the two platforms greatly improves the coverage
of the metabolome and as such should be a firstchoice for
exploratory studies of the complex biological matrixes.
Work was conducted with the application of the Tomsk regio-
nal common use center technical equipment acquired thanks to a
grant of the Russian Ministry of the Agreement No. 14.594.21.0001
(RFMEFI59414X0001). This project is supported by ‘‘The Tomsk State
University Academic D.I. Mendeleev Fund Program” under Grant
(No. 18.1.52.2015).
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Background: Breast cancer, particularly invasive carcinoma of
no special type (IC NST), demonstrates considerable intratumor
morphological heterogeneity. Five types of morphological struc-
tures representing different architectural arrangements of tumor
cells – tubular, alveolar, trabecular, solid structures, and discrete
groups have been described in IC NST. Previous studies reported
the contribution of intratumor morphological heterogeneity of
IC NST to chemotherapy efficiency and lymph node metastasis
(Zavyalova et al., 2013; Denisov et al., 2014); however, its role in
distant metastasis remains unidentified. Aim: to study the
contribution of intratumor morphological heterogeneity of IC
NST to distant metastasis and to identify gene expression fea-
tures of metastatic behavior of different morphological structures.
Materials and methods: 358 IC NST patients (age range 29–90,
mean age 49.8  9.5, T1-4N0-3M0-1) treated with neoadjuvant
chemotherapy (NAC) have been enrolled in this study.
Chi-square test and Kaplan–Meier analysis were used to estimate
the association between the presence of certain morphological
structures in breast tumors and the frequency of distant metasta-
sis and metastasis-free survival. qRT-PCR was applied for mea-
surement of the expression levels of genes involved in cell
motility (CDH1, CDH2, CDH3, CTNNA1, CTNNB1, ITGA6, ITGAV,
ITGB1, ITGB3, ITGB4, SNAIL, MMP14, ROCK2, L1CAM, MMP2,
MMP9, PDPN) and pre-metastatic niche formation (TNFa, TGFb,
VEGFa, LOX, M-CSF, GM-CSF, HIF1A, SDF2) in different morpholog-
ical structures isolated from breast tumors (n = 4) by laser
microdissection.
Results: Patients with alveolar structures in breast tumors
more frequently displayed distant metastasis than cases without
this morphological variant (71.9% vs. 56.5%; p = 0.004). The
association between alveolar structures and high frequency of
hematogenous metastasis was found only in patients with poor
response to NAC (p = 0.003), but not in cases with good
chemotherapy efficiency (p = 0.377). Increased distant metastasis
was also shown in patients with trabecular structures as com-
pared to cases without this morphological type (88.3% vs. 70.0%;
p = 0.0001). Kaplan–Meier analysis demonstrated a significantly
higher probability of developing metastasis in patients with alve-
olar or trabecular structures in breast tumors (p = 0.011). No sig-
nificant association between other morphological structures
and distant metastasis was found. Expression analysis showed
the presence of cell motility phenotype in all morphological
structures. In particular, we found changes in cell adhesion gene
expression, which declined in the row: solid–alveolar–trabecular
structures–discrete groups of tumor cells (p < 0.05). In addition,
almost all structures demonstrated SNAIL and ROCK2 gene
expression, and there were differences in expression of other cell
migration genes between morphological structures. For example,
PDPN was observed to be expressed in solid and alveolar
structures, whereas L1CAM – in trabecular, tubular structures
and discrete groups of some breast tumors. The expression of
pre-metastatic niche genes also varied between distinct
structures and, in general, declined in the row: alveolar–solid–
trabecular structures–discrete groups of tumor cells (p < 0.05).
Conclusion: Intratumor morphological heterogeneity of IC NST
contributes to distant metastasis probably by variations in
expression of genes involved in cell motility and pre-metastatic
niche formation between different morphological structures.
The study was supported by the Russian Scientific Foundation
(Grant #14-15-00318).
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Background: Cystatins are natural endogenous inhibitors of
cysteine proteases universally involved into development of dif-
ferent tumors. Tumor growth and metastazing include increased
consumption of these inhibitors, followed by decreased level of
cystatins and dysregulation of proteases/protease inhibitors sys-
tem. However, the biological role of individual cystatins is still
not clear. The most known cystatin C was shown to relate to
some types of tumor development. Cystatins include a group of
intracellular cystatins (belonging to type 1) and extracellular cys-
tatins (type 2), among them cystatins C, D, E/M, F, G, S, SN and SA,
which functions were not studied enough. It was suggested that
cystatin SN was responsible in regulation of tumor growth locally.
The aim: To investigate cystatin C and cystatin SN concentra-
tions in biological fluids of patients with intraocular melanoma
as tumor biomarkers and possible therapy targets.
Materials and methods: The patients with melanoma chori-
oidea (57 patients; among them woman 36, men 21; aged from
28 to 80, of middle age of 56.6 ± 2.4 years) were under investiga-
tion. In all cases the pathological process involved one eye. The
control group consisted of 37 healthy persons (volunteers), med-
ical personnel in clinic and students, aged from 20 to 49 years; the
middle age 31 ± 4.1 years); 7 patients with age-related cataract
aged from 57 to 80 (middle age 71 ± 2.6 years; man 3, woman 4).
The biological fluids studied: tears, intraocular fluid (obtained
during operation) and blood serum. In all cases investigation
was made according to informed agreement of patients and con-
trol group members. Cystatins concentration was measured by
ELISA kits: for Cystatin C (BioVendor, Chechia) and for cystatin
SN with help of Human Cystatin SN (CST1) Elisa Kit Cusabio,
China. Statistical analysis was made by non-parametric statistic
test of Kruskal–Wallis, for correlations – Spearman test. The
difference between groups studied was considered significant
p < 0.05.
Results: Increased serum level of cystatin C was revealed in
patients with melanoma chorioides (1023.5 ± 78.9 ng/ml,
p = 0.019) compared with the control (809.9 ± 146.8 ng/ml). In tears
of patients with melanoma chorioidea, cystatin C concentration
(441.7 ± 14.5 ng/ml) had a tendency to increase as compared to
the data obtained in tears of the control group (287.5 ± 20.01 ng/ml)
as well as the cystatin C level of intraocular fluid of these patients
vs the control group (p < 0.1). Cystatin SN concentration in serum
of patients with melanoma chorioidea (1.45 ± 0.30 ng/ml) was
lower vs the control group (3.12 ± 0.32 ng/ml, p = 0.0038), as well
as Cystatin SN level in intraocular fluid (1.43 ± 0.10 ng/ml) vs the
control (2.60 ± 0.60 ng/ml, p < 0.05). There was no difference in
cystatin SN concentration in tears of patients and control group.
Conclusion: In serum of control (healthy) group, cystatin C
concentration is significantly higher than cystatin SN level in
serum, tears and intraocular fluid. The reverse correlation was
revealed between the level of these inhibitors in serum, that is
suggested their possible interaction. In melanoma patients the
reciprocal changes in cystatin C and cystatin SN were shown:
increased cystatin C and decreased cystatin SN level in all
biological fluids studied. On the basis of cystatins distribution in
biological fluids of patients one can suggest their involvement
in pathological process as system reaction of organism on tumor
development.
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Background: To determine diagnostic importance of DNA
methylation in patients with chronic atrophic gastritis and induc-
tion of ‘‘Correa” cascade for gastric cancer prevention.
Material and methods: This present study included 80 patients
with chronic atrophic gastritis associated with Helicobacter pylori.
Diagnoses were confirmed by endoscopic, morphologic, serologic
examinations. Age of patients varied from 17 to 78 years old.
There were 52 (65%) males and 28 (35%) females. The control
group consisted of 32 patients with morphological verified diag-
nosis of stage I–II gastric cancer. Examination with the purpose
to determine hypermethylation of DNA was performed simulta-
neously in biopsy materials and blood plasma. Provoking factors
of hypermethylation in 4 tumors’ genes, APE, E-Cadherin,
T1MP3, hMLHI were determined by quantitative methylation with
use of Polymerase Chain Reaction. To evaluate the level of methy-
lation we compared the analysis’ results of biopsy and blood
plasma tests. Blood serum samples and biopsy specimens were
collected at diagnosis until the therapy is started. All patients
with chronic atrophic gastritis infected with H. pylori underwent
anti-H. pylori therapy according to the protocol. Chronic atrophic
gastritis was found at morphologic examination in 40 (50%)
patients according to ‘‘Correa” cascade. 36 (45%) patients had
intestinal metaplasia, and 4 (5%) patients had dysplasia. Reaction
was considered to be positive in cases, when the level of methy-
lation in genes listed above was higher in blood serum than in
biopsy materials.
Results: High concentrations of methylated APE, T1MP3 and
hMLIH in genes were found in blood serum of 8 (10%) patients.
In the control group, all 32 patients with gastric cancer had high
methylation level in blood serum. In the remaining 72 (90%)
patients, no high concentration of DNA methylation was found.
After the 2-nd course of anti-H. pylori therapy, patients underwent
morphologic and endoscopic examinations according to the
protocol. Eradication of H. pylori was determined in 86% patients
who received therapy. Intestinal metaplasia decreased from 45%
to 25% (20 patients). Mild dysplasia was found in 1.2% of cases.
Repeated analysis of methylation level showed its decrease after
anti-H. pylori therapy in 4 (50%) out of 8 patients.
Conclusion: Genetic tests show that DNA methylation in
patients with chronic atrophic gastritis has high diagnostic
importance. Anti-H. pylori therapy at the different stages of
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